Insider · CIK 0001838114
Freddy A. Jimenez
Files at CLDX (Celldex Therapeutics, Inc.). First filing Aug 15, 2025, latest Dec 8, 2025.
Freddy A. Jimenez files SEC Form 4 as officer at CLDX (Celldex Therapeutics, Inc.). Since Aug 15, 2025, Freddy A. Jimenez has reported 0 open-market buys worth $0 and 2 open-market sells worth $140k, the latest filed on Dec 8, 2025.
A track record needs three past buys with six months of prices behind them; Freddy A. Jimenez has 0, so none is measured yet.
The newest scored trade: sold $121k of CLDX on Dec 4, 2025, filed Dec 8, 2025, scored 30 (weak). In the last 12 months: 0 buys worth $0 and 1 sell worth $121k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CLDX: Celldex Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | CLDXsell Celldex Therapeutics, Inc. | $121k 4,166 shares | -12% | +96% from low0% from high | |
| 15Weak | CLDXsell Celldex Therapeutics, Inc. | $19k 771 shares | -2% | +65% from low-43% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 4, 2025 | CLDX CELLDEX THERAPEUTICS, INC. | 4,166 0.01% of outstanding | $121k | Dec 4, 2025 | none |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 25, 2026 | CLDX Celldex Therapeutics, Inc. | AGrant or award Incentive Stock Option (right to buy)derivative | +93,000 | $0.00 | $0 | 93,000 | Jun 29, 2026 |
| Dec 4, 2025 | CLDX Celldex Therapeutics, Inc. | SOpen-market sale Common Stock | -4,166 | $29.10 | $121k | 30,796 | Dec 8, 2025 |
| Aug 13, 2025 | CLDX Celldex Therapeutics, Inc. | SOpen-market sale Common Stock | -341 | $23.95 | $8,167 | 35,392 | Aug 15, 2025 |
| Aug 13, 2025 | CLDX Celldex Therapeutics, Inc. | SOpen-market sale Common Stock | -430 | $25.42 | $11k | 34,962 | Aug 15, 2025 |
| Jun 5, 2025 | CLDX Celldex Therapeutics, Inc. | AGrant or award Incentive Stock Option (right to buy)derivative | +75,000 | $0.00 | $0 | 75,000 | Jun 9, 2025 |
Questions about Freddy A. Jimenez
Answered from the filings on this page, as of the latest one.
Is Freddy A. Jimenez buying or selling?
In the last 12 months Freddy A. Jimenez reported 0 open-market buys worth $0 and 1 open-market sell worth $121k on SEC Form 4; the latest was sold $121k of CLDX on Dec 4, 2025. Grants, option exercises and tax withholding are not counted.
How did Freddy A. Jimenez's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Freddy A. Jimenez has 0.
Where does Freddy A. Jimenez file Form 4?
Freddy A. Jimenez has filed Form 4 at CLDX (Celldex Therapeutics, Inc.) as SVP & GENERAL COUNSEL. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.